Document is current
Any future updates will be listed below
-
Authors
Dahlqvist, Julia R. https://orcid.org/0000-0002-3149-1661
Oestergaard, Sofie T.
Poulsen, Nanna S.
Knak, Kirsten Lykke
Thomsen, Carsten
Vissing, John
-
Funding
Funding for this research was provided by:
Augustinus Fonden
Aase og Ejnar Danielsens Fond
- License Information
-
More Information
Article History
Received: 11 December 2018
Accepted: 5 March 2019
First Online: 18 March 2019
Competing Interests
: J. Vissing has received research and travel support, speaker honoraria from and/or served as consultant on advisory boards for Sanofi/Genzyme, Ultragenyx Pharmaceuticals, and Santhera Pharmaceuticals, Sarepta Therapeutics, Audentes Therapeutics, and Stealth Biotherapeutics. J. Dahlqvist reports no disclosures. S. Oestergaard reports no disclosures. N. Poulsen reports no disclosures. K. Knak reports no disclosures. C. Thomsen reports no disclosures.
